Table 1 Patient characteristics at first clinical ISR presentation
Parameter | Total (n = 191) | ACS cohort (n = 118) | Non-ACS cohort (n = 73) | P value |
|---|---|---|---|---|
Demographics | ||||
Age | 61 ± 10 | 62 ± 10 | 59 ± 10 | 0.074 |
Men | 155 (81.2%) | 90 (76.3%) | 65 (89.0%) | 0.036 |
BMI | 23.5 ± 3.5 | 23.7 ± 3.9 | 23.1 ± 2.7 | 0.479 |
Clinical characteristics | ||||
Diabetes | 109 (57.1%) | 68 (57.6%) | 41 (56.2%) | 0.881 |
Hypertensionƚ | 104 (54.5%) | 66 (55.9%) | 38 (52.1%) | 0.655 |
Chronic kidney disease | 21 (11.0%) | 18 (15.3%) | 3 (4.1%) | 0.017 |
Acute kidney injury | 32 (16.8%) | 24 (20.3%) | 8 (11.0%) | 0.112 |
Dyslipidemia* | 98 (67.1%) | 55 (63.2%) | 43 (72.9%) | 0.282 |
Current tobacco use | 39 (20.4%) | 22 (18.6%) | 17 (23.3%) | 0.464 |
CCF | 34 (17.8%) | 30 (25.4%) | 4 (5.5%) | < 0.001 |
NYHA 3,4 | 20 (10.5%) | 14 (11.9%) | 6 (8.2%) | 0.476 |
LVEF | 53 ± 11 | 51 ± 10 | 54 ± 11 | 0.076 |
Previous MI | 100 (52.4%) | 65 (55.1%) | 35 (47.9%) | 0.373 |
Previous CABG | 14 (7.3%) | 9 (7.6%) | 5 (6.8%) | 1.000 |
Statin therapy | 163 (85.3%) | 99 (83.9%) | 64 (87.7%) | 0.533 |
Lipid profile* (mg/dL) | ||||
Total cholesterol | 145 ± 42 | 146 ± 45 | 144 ± 37 | 0.785 |
LDL | 80 ± 35 | 80 ± 38 | 79 ± 31 | 0.896 |
HDL | 39 ± 12 | 41 ± 13 | 38 ± 10 | 0.126 |
Triglycerides | 130 ± 71 | 124 ± 67 | 140 ± 76 | 0.166 |